Blood tests showed no remarkable findings, and the levels of tumor markers, such as carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), and squamous cell carcinoma (SCC) antigen, were all within the standard values. The gene discussed is CEACAM5; the disease is squamous cell carcinoma.